Aisling Capital Management LP Nuvation Bio Inc. Transaction History
Aisling Capital Management LP
- $292 Million
- Q1 2024
A detailed history of Aisling Capital Management LP transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Aisling Capital Management LP holds 2,541,009 shares of NUVB stock, worth $7.42 Million. This represents 3.17% of its overall portfolio holdings.
Number of Shares
2,541,009
Previous 2,541,009
-0.0%
Holding current value
$7.42 Million
Previous $3.84 Million
141.11%
% of portfolio
3.17%
Previous 1.15%
Shares
1 transactions
Others Institutions Holding NUVB
# of Institutions
126Shares Held
107MCall Options Held
40.6KPut Options Held
2.9K-
Eco R1 Capital, LLC San Francisco, CA19.2MShares$56.1 Million1.99% of portfolio
-
Omega Fund Management, LLC Boston, MA14.1MShares$41.1 Million53.03% of portfolio
-
Black Rock Inc. New York, NY12.5MShares$36.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.53MShares$22 Million0.0% of portfolio
-
David Abrams Abrams Capital Management, L.P. | Boston, Ma3.81MShares$11.1 Million0.47% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $634M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...